Ubs Group Ag Pure Tech Health PLC Put Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRTC
# of Institutions
9Shares Held
353KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC243KShares$4.25 Million0.19% of portfolio
-
Pentwater Capital Management LP Naples, FL50KShares$875,0000.01% of portfolio
-
Portolan Capital Management, LLC Boston, MA27.8KShares$486,4120.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny23.9KShares$417,4970.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$128,1700.04% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $488M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...